For what it’s worth, I am not surprised at the company’s minimalistic approach to communications. Both Dr Wong and Dr Johansson have prior track records as clinical/laboratory researchers. They are quiet, cautious, thoughtful people who will not want to make a wrong move at a critical time. I think for them the end result is all that matters - for the company, patients, medical science, and investors alike. They know journals and congresses take embargoes very seriously. We’re impatient for personal reasons! They have to look at the big picture.